Dr. Linda Ehrlich-Jones works in the Center for Rehabilitation Outcomes Research. She has been involved in creation of behavioral interventions, using motivational interviewing, targeting persons with chronic illness to increase physical activity and improve diet. She oversees the Rehabilitation Measures Database, a compendium of summaries of instruments utilized by rehabilitation professionals. Her faculty appointments at Northwestern University Feinberg School of Medicine include Physical Medicine & Rehabilitation and the Institute for Public Health and Medicine.
Past-President Association of Rheumatology Health Professionals
Recipient of the Addie Thomas Service Award (Association of Rheumatology Health Professionals, 2014)
Group Leader in Arthritis and Lupus Research Group, Department of Medicine, Monash University.
Senior lecturer psychology at the University of Portsmouth. Before that group leader of the group “Evolutionary Roots of Human Social Interaction” at the Max Planck Institute EVAN Germany. Junior Research Fellow at Churchill College and a member of the Experimental Psychology lab of Cambridge University.
Main research interest is the evolution of human sociality. Special interest in ToM, cooperation and communication among individuals.
Sandra Kleinau obtained her Ph.D. in clinical immunology from Uppsala University (UU), Sweden and performed postdoctoral studies at Karolinska Institute in Stockholm and later at UU. She established her own research group in 1997, received a permanent position at UU in 2004 and became Professor of Biology in 2008. Dr Kleinau has a research interest in autoimmunity, articularly autoimmune arthritis; how self reactive lymphocytes and antibodies develop and by which mechanisms they induce chronic inflammation.
Professor of Experimental Rheumatology, University Medical Centre Utrecht. Manager of research and head of research laboratory of the department of Rheumatology & Clinical Immunology, UMCU. In addition to organization, initiation, and facilitation research of the department, there is a personal interest in a unique treatment of severe osteoarthritis being joint distraction, and in a unique animal model of osteoarthritis being the canine Groove model.
Academic Editor PLoS ONE. Recipient of the 2006 Rupert Timpl Award from the International Society for Matrix Biology.
My research goals are to characterise the mechanisms of collagenous tissue development, repair and renewal. Current research interests include understanding the dynamics of collagen synthesis and turnover, the role of stem cells in musculoskeletal homeostasis and the role of glucose in musculoskeletal ageing. Tissues of interest are primarily tendon and ligament but include cartilage, bone, cornea and intervertebral disc, as well as fibrotic tissue.
This research is important because age-related degeneration and loss of function in musculoskeletal tissues is associated with chronic joint pain, limited movement, tendinopathy, ligament damage, intervertebral disc degeneration and osteoarthritis. There is both a loss of tissue integrity and propensity to fibrosis indicating that homeostasis of the collagenous extracellular matrix is lost with age. Understanding the molecular processes that create functional musculoskeletal tissues during development and growth, and which malfunction or cease to operate in aged tissues is key to developing new strategies for tissue engineering, to activate intrinsic stem cell repair mechanisms and to develop beneficial pharmaceutical, dietary or exercise-based interventions in an increasingly aged society.
Full Professor and Senior Lecturer - Faculty and Nursing, Universidade da Coruña, Spain
Director - Research, Health and Podiatry Unit, Department of Health Sciences, Faculty of Nursing and Podiatry, Universidade da Coruña, Spain
Dr. Kutty Selva Nandakumar (h-index: 37) is Professor of Pharmacology in the School of Pharmaceutical Sciences, Guangzhou, China. He is an international scientist and has 28 years of research experience from three different countries (India, Sweden and China). He has research experience in Rheumatology, Tumor Immunology and Salmonellosis/Typhoid Fever.
Dr. Nguyen is a Principal Fellow and Lab Head of the Garvan Institute of Medical Research (Australia). He also holds joint appointments as Professor, St Vincent's Clinical School, University of New South Wales (UNSW Sydney); Professor of Predictive Medicine at the University of Technology Sydney (UTS); and conjoint Professor of Epidemiology and Biostatistics at the School of Medicine, University of Notre Dame Australia.
- 1988 Medical Degree
- 1991 Project Research performed abroad Italy. University of Umeå, Sweden
- 1993 Italian Ph.D. in Experimental Medicine, University of Perugia
- 1997 Specialisation in Clinical Pathology, Perugia University Medical School
- 2000-2006 Researcher,
- 2006-present. Associate Professor. University of Perugia.
- 2001-2006: Chair of Pharmacology, School of Motor and Sport Sciences, University of Perugia.
- 2006-present: Chair of Pharmacology, Medical School. University of Perugia.
- 2015-present: Coordinator of PhD School on "Pharmacological Biotecnology and Clinical Pharmacology”, University of Perugia
- Member of the "Italian Society of Pharmacology" (SIF)
- Member of the “European Academy of Sciences and Arts”
PUBLICATIONS AND METRICS
Publications in peer reviewed international journals: 91
Carlo Pucillo is a Full Professor in Immunology at the School of Medicine of the University of Udine.
In his scientific career Prof. Carlo Pucillo has studied the "non canonical function" of MHC class II and the molecular mechanism that regulate the B cell activation and differentiation. From 2-1991 to 6-1994 Dr Pucillo has been Visiting Scientist at NCI in Bethesda, MD-USA.
He has acquired a considerable expertise in advanced molecular biology analysis as well as a good understanding of the immunobiology of the immune response, of the non canonical function of MHC class II molecules, in particular, as documented by his publications on this subjects.
He has also investigated the signal transduction pathways elicited by T-B cell interaction via CD40-CD154. CD40 is a B cell surface receptor that belongs to the pleiotropic tumor necrosis factor receptor (TNFR) superfamily. The interaction between CD40 and its ligand promotes proliferation, cytokine production, upregulation of various surface molecules involved in antigen presentation, germinal center and memory B cell formation antibody isotype switching and affinity maturation and the B cell life span.
Most recently, his interest is in the study of regulatory role of Mast Cells in the microenvironment and subsequently in the tissutal tolerance and adaptive immune response. This body of work may provide a conceptual framework to therapeutically manipulate these responses in the settings of autoimmune disease and cancer.
Study of Medicine at the Ruprecht-Karls-Universiy in Heidelberg, Germany; Habilitation in Experimental Virology. Head of Clinical Research at the Department of Pediatrics, University Hospital Carl Gustav Carus at TU Dresden, Germany, since 1995. Speaker of Clinical Research Unit 249 "Defects of the Innate Immune System in Autoinflammation and Autoimmunity" since 2010